As Pdpn deletion in T-cells has recently been shown to significantly delay melanoma growth due to PDPN's newly discovered role as co-inhibitory receptor (46, 47), we tested whether the application of the Csfr1-Cre line resulted in the undesired deletion of Pdpn in T-lymphocytes. The gene discussed is PDPN; the disease is melanoma.